IL33 and Sepsis: We found that circulating IL‐33 levels were detectable in significantly more patients in the sepsis group (77%, 10/13) than in the control group (42%, 11/26) (Figure 1F), and the serum IL‐33 levels in other patients were below the limit of detection of the enzyme‐linked immunosorbent assay (ELISA).